Study of bacterial uropathogenes and furazidin susceptibility (FUSE)

• Research type

  Research Study

• Full title

  European Surveillance Study of bacterial uropathogenes and furazidin susceptibility – non-interventional in vitro study (FUSE).

• IRAS ID

  302838

• Contact name

  Daben Dawam

• Contact email

  Daben.Dawam@southend.nhs.uk

• Sponsor organisation

  ADAMED PHARMA S.A.

• Duration of Study in the UK

  0 years, 1 months, 31 days

• Research summary

  This is a non-interventional, observational, multicenter, international study for obtaining bacterial uropathogenes, using urine samples from UTI (acute and/or recurrent) patients to assess sensitivity to in-vitro furazidin assessment.

• REC name

  South Central - Berkshire B Research Ethics Committee

• REC reference

  21/SC/0362

• Date of REC Opinion

  21 Dec 2021

• REC opinion

  Further Information Favourable Opinion